HESR1/CHF2 suppresses VEGFR2 transcription independent of binding to E-boxes

被引:34
作者
Holderfield, Matthew T.
Henderson Anderson, April M.
Kokubo, Hiroki
Chin, Michael T.
Johnson, Randy L.
Hughes, Christopher C. W. [1 ]
机构
[1] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Program Genes & Dev, Houston, TX 77030 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Dept Vasc Med Res, Boston, MA 02115 USA
关键词
endothelial; angiogenesis; tube formation; bHLH transcription factor; Hey1; notch; KDR;
D O I
10.1016/j.bbrc.2006.05.177
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The bHLH transcription factor HESR1 (CHF2) acts downstream of notch to regulate cardiovascular development and angiogenesis, at least in part through down-regulation of the VEGF receptor, VEGFR2. Surprisingly, we find that HESR1 interacts with the promoter in endothelial cells (EC) not through direct binding to the E-boxes, but through intermediary interactions with GC-box-binding proteins. The bHLH and orange domains of HESR I are sufficient for repression in EC, likely through recruitment of co-repressors, however, the C-terminal YRPW motif is not required. The VEGFR2 promoter contains a functional initiator element but no TATA box, however, addition of a TATA sequence renders the promoter resistant to inhibition by HESR1. In agreement with this finding, the NrCAM, TK, and CMV promoters, which have TATA boxes, cannot be repressed. Thus, HESR1 represses VEGFR2 through interactions with SP-1-like factors and requires an Inr element in the absence of a TATA box. Our findings illuminate an important mechanism for notch/ HESR1 regulation of VEGF-induced angiogenesis. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:637 / 648
页数:12
相关论文
共 34 条
[1]  
Biesiada E, 1999, MOL CELL BIOL, V19, P2577
[2]   Angiogenesis in health and disease [J].
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (06) :653-660
[3]   Cardiovascular basic helix loop helix factor 1, a novel transcriptional repressor expressed preferentially in the developing and adult cardiovascular system [J].
Chin, MT ;
Maemura, K ;
Fukumoto, S ;
Jain, MK ;
Layne, MD ;
Watanabe, M ;
Hsieh, CM ;
Lee, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (09) :6381-6387
[4]  
DAWSON SR, 1995, MOL CELL BIOL, V15, P6923
[5]   The biology of VEGF and its receptors [J].
Ferrara, N ;
Gerber, HP ;
LeCouter, J .
NATURE MEDICINE, 2003, 9 (06) :669-676
[6]   Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development [J].
Gale, NW ;
Dominguez, MG ;
Noguera, I ;
Pan, L ;
Hughes, V ;
Valenzuela, DM ;
Murphy, AJ ;
Adams, NC ;
Lin, HC ;
Holash, J ;
Thurston, G ;
Yancopoulos, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (45) :15949-15954
[7]   Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence [J].
Hata, Y ;
Duh, E ;
Zhang, K ;
Robinson, GS ;
Aiello, LP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (30) :19294-19303
[8]   The basic helix-loop-helix transcription factor HESR1 regulates endothelial cell tube formation [J].
Henderson, AM ;
Wang, SJ ;
Taylor, AC ;
Aitkenhead, M ;
Hughes, CCW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (09) :6169-6176
[9]   HERP, a novel heterodimer partner of HES/E(spl) in notch signaling [J].
Iso, T ;
Sartorelli, V ;
Poizat, C ;
Iezzi, S ;
Wu, HY ;
Chung, G ;
Kedes, L ;
Hamamori, Y .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (17) :6080-6089
[10]   HERP, a new primary target of notch regulated by ligand binding [J].
Iso, T ;
Sartorelli, V ;
Chung, G ;
Shichinohe, T ;
Kedes, L ;
Hamamori, Y .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (17) :6071-6079